Post Content
This panel brings together leaders from AITEM, CytoReason, Superluminal Medicines, and Therapyside, showcasing how NVIDIA inference microservices (NIMs), AI blueprints, and BioNeMo are driving advances in diagnostics, therapy workflows, and drug development. Through a technical and forward-looking discussion, we’ll explore how these innovators are integrating AI into their systems, overcoming challenges, and shaping a future where technology fundamentally transforms patient care and advances the potential for better health for all.
Follow us:
X: https://nvda.ws/4hi2sxB
LinkedIn: https://nvda.ws/4eSlE3B
Subscribe to the NVIDIA AI Healthcare Newsletter: https://nvda.ws/4eS1F54 Read More NVIDIA
#Techno #nvidia
